The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Hemochromatosis Treatment Market 2026
US$ 2,999.00
The Hemochromatosis Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.057 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
November 2025
217 pages
Hemoglobinopathies Market 2026
US$ 2,999.00
The Hemoglobinopathies Market was valued at in and is anticipated to reach by , at a CAGR of 0.107 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
243 pages
Hemophilia A Treatment Market - 2022-2031
US$ 2,999.00
The Hemophilia A Treatment Market was valued at US$ 9.1 billion in 2022 and is anticipated to reach US$ 13.3 billion by 2031, at a CAGR of 0.05 from 2026 to 2032. The report delivers in-depth insights...
November 2025
218 pages
Hepatorenal Syndrome Market 2026
US$ 2,999.00
The Hepatorenal Syndrome Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
219 pages
Hereditary Angioedema Therapeutics Market - 2022
US$ 2,999.00
The Hereditary Angioedema Therapeutics Market was valued at USD 2.9 billion in 2022 and is anticipated to reach by , at a CAGR of 0.086 from 2026 to 2032. The report delivers in-depth insights into ke...
November 2025
200 pages
Human Chorionic Gonadotropic Market 2026
US$ 2,999.00
The Human Chorionic Gonadotropic Market was valued at in and is anticipated to reach by , at a CAGR of 0.073 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
243 pages
Hyaluronidase Market 2026
US$ 2,999.00
The Hyaluronidase Market was valued at in and is anticipated to reach by , at a CAGR of 0.08 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growt...
November 2025
223 pages
Hyperammonemia Market 2026
US$ 2,999.00
The Hyperammonemia Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growt...
November 2025
219 pages
Hypercalcemia Treatment Market 2026
US$ 2,999.00
The Hypercalcemia Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
November 2025
243 pages
Hyperkalemia Drugs Market 20262031
US$ 2,999.00
The Hyperkalemia Drugs Market was valued at in and is anticipated to reach by 2031, at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...
November 2025
207 pages
Hyperphosphatemia Treatment Market 2026
US$ 2,999.00
The Hyperphosphatemia Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
November 2025
210 pages
Hypofibrinogenemia Market 2026
US$ 2,999.00
The Hypofibrinogenemia Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional g...
November 2025
223 pages
Hypoxia Treatment Market - 2022-2030
US$ 2,999.00
The Hypoxia Treatment Market was valued at US$ 77.6 million in 2022 and is anticipated to reach US$ 134.3 million by 2030, at a CAGR of 0.072 from 2026 to 2032. The report delivers in-depth insights i...
November 2025
217 pages
IgG4-Related Disease Market 2026
US$ 2,999.00
The IgG4-Related Disease Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
219 pages
Immunosuppressants Drugs Market 2026
US$ 2,999.00
The Immunosuppressants Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.04 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
November 2025
243 pages
India Tapentadol Market - 2023-2031
US$ 2,999.00
The India Tapentadol Market was valued at US$ 28.24 million in 2023 and is anticipated to reach US$ 45.55 million by 2031, at a CAGR of 0.062 from 2026 to 2032. The report delivers in-depth insights i...
November 2025
223 pages
Interstitial Cystitis Drugs Market 2026
US$ 2,999.00
The Interstitial Cystitis Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.0528 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
200 pages
Intra-Dialytic Hypotension (IDH) Market 2026
US$ 2,999.00
The Intra-Dialytic Hypotension (IDH) Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includ...
November 2025
220 pages
Intravenous Iron Drugs Market 2026
US$ 2,999.00
The Intravenous Iron Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.081 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
November 2025
200 pages
Ion Channel Modulators Market 2026
US$ 2,999.00
The Ion Channel Modulators Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...
November 2025
223 pages
Iron Overload Syndrome Treatment Market 2026
US$ 2,999.00
The Iron Overload Syndrome Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includ...
November 2025
217 pages
Juvenile Dermatomyositis Treatment Market - 2023-2031
US$ 2,999.00
The Juvenile Dermatomyositis Treatment Market was valued at US$ 71.15 million in 2023 and is anticipated to reach US$ 101.93 million by 2031, at a CAGR of 0.046 from 2026 to 2032. The report delivers...
November 2025
200 pages
Klinefelter Syndrome Treatment Market 2026
US$ 2,999.00
The Klinefelter Syndrome Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
217 pages
Lactated Ringers Injection Market 2026
US$ 2,999.00
The Lactated Ringers Injection Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...
November 2025
223 pages
Latin America Liver Disease Treatment Market - 2023-2031
US$ 2,999.00
The Latin America Liver Disease Treatment Market was valued at US$ 1.3 billion in 2023 and is anticipated to reach US$ 2.02 billion by 2031, at a CAGR of 0.058 from 2026 to 2032. The report delivers i...
November 2025
220 pages
Marfan Syndrome Treatment Market - 2023-2031
US$ 2,999.00
The Marfan Syndrome Treatment Market was valued at US$ 203.5 million in 2023 and is anticipated to reach US$ 312.6 million by 2031, at a CAGR of 0.056 from 2026 to 2032. The report delivers in-depth i...
November 2025
207 pages
Membranous Nephropathy Market 2026
US$ 2,999.00
The Membranous Nephropathy Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...
November 2025
200 pages
Metronidazole Capsule Market 2026
US$ 2,999.00
The Metronidazole Capsule Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
November 2025
217 pages
Microscopic Polyangiitis (MPA) Treatment Market 20262031
US$ 2,999.00
The Microscopic Polyangiitis (MPA) Treatment Market was valued at in and is anticipated to reach by 2031, at a CAGR of 0.055 from 2026 to 2032. The report delivers in-depth insights into key market dy...
November 2025
207 pages
Mitochondrial Myopathies Treatment Market 2026
US$ 2,999.00
The Mitochondrial Myopathies Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...
November 2025
223 pages
Motion Sickness Treatment Market 2026
US$ 2,999.00
The Motion Sickness Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.03 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...
November 2025
217 pages
Mucinoses Market 2026
US$ 2,999.00
The Mucinoses Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tre...
November 2025
207 pages
Myotonic Dystrophy Treatment Market 2026
US$ 2,999.00
The Myotonic Dystrophy Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
November 2025
218 pages
Nephrology Drugs Market 2026
US$ 2,999.00
The Nephrology Drugs Market was valued at in and is anticipated to reach by , at a CAGR of 0.0457 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
207 pages
Nephrotic Syndrome Drugs Market - 2023-2030
US$ 2,999.00
The Nephrotic Syndrome Drugs Market was valued at US$ 423.7 million in 2023 and is anticipated to reach US$ 645.3 million by 2030, at a CAGR of 0.054 from 2026 to 2032. The report delivers in-depth in...
November 2025
243 pages
Neurocutaneous Syndrome Market 2026
US$ 2,999.00
The Neurocutaneous Syndrome Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
November 2025
220 pages
Neurometabolic Disorders Market 2026
US$ 2,999.00
The Neurometabolic Disorders Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regi...
November 2025
207 pages
Non-Opioid Pain Treatment Market 2026
US$ 2,999.00
The Non-Opioid Pain Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.08 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...
November 2025
219 pages
Osteoporosis Drugs Market - 2022
US$ 2,999.00
The Osteoporosis Drugs Market was valued at US$ 14,066.4 million in 2022 and is anticipated to reach by , at a CAGR of 0.041 from 2026 to 2032. The report delivers in-depth insights into key market dy...
November 2025
223 pages
Overactive Bladder Treatment Market 2026
US$ 2,999.00
The Overactive Bladder Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.036 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
200 pages
Overt Hepatic Encephalopathy Treatment Market 2026
US$ 2,999.00
The Overt Hepatic Encephalopathy Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
November 2025
223 pages
Pain Relief Medication Market 2026
US$ 2,999.00
The Pain Relief Medication Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...
November 2025
210 pages
Paroxysmal Nocturnal Hemoglobinuria Treatment Market 2026
US$ 2,999.00
The Paroxysmal Nocturnal Hemoglobinuria Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.114 from 2026 to 2032. The report delivers in-depth insights into key market d...
November 2025
200 pages
Penicillin Drug Market 2026
US$ 2,999.00
The Penicillin Drug Market was valued at in and is anticipated to reach by , at a CAGR of 0.044 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional gr...
November 2025
220 pages
Phenylephrine Hydrochloride Market 2026
US$ 2,999.00
The Phenylephrine Hydrochloride Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
November 2025
207 pages
